Interesting article - biotech / ICT, page-5

You sure about that? Each of those stocks is now trading at many multiples of both their price and market cap prior to their transactions. they may have pulled back a bit from their highs but still retain decent market caps and plenty of capital was raised.

I wouldn't say they were lucky I would say those behind the scenes chose a biotech asset to introduce as that's where the interest was at the time. They raised heaps of capital. I would say each transaction was actually very successful.

Forrest actually shifted their focus from mining to Biotech a few years ago, so definitely not just lucky. DYOR on management and you'll see what they can do.

Not sure why you are so consistently negative about this stock that you continue to hold Aviya, especially when the management team is totally different- I am guessing you are down by such an amount that it would take something like a 20 bagger to break even?